Alliancebernstein L.P. Nevro Corp Transaction History

Alliancebernstein L.P.

$280 Billion
Q4 2024

A detailed history of Alliancebernstein L.P. transactions in Nevro Corp stock. As of the latest transaction made, Alliancebernstein L.P. holds 51,570 shares of NVRO stock, worth $295,496. This represents 0.0% of its overall portfolio holdings.

Number of Shares

51,570

Previous 51,570 -0.0%

Holding current value

$295,496

Previous $287,000 33.45%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$4.71 - $10.1 $6,123 - $13,130	-1,300 Reduced 2.46%	51,570 $287,000
Q2 2024 Aug 14, 2024	BUY	$7.96 - $13.59 $128,713 - $219,750	16,170 Added 44.06%	52,870 $445,000
Q1 2024 May 14, 2024	SELL	$13.56 - $20.78 $61,020 - $93,510	-4,500 Reduced 10.92%	36,700 $529,000
Q1 2023 May 15, 2023	SELL	$30.17 - $41.11 $6,365 - $8,674	-211 Reduced 0.51%	41,200 $1.49 Million
Q4 2022 Feb 14, 2023	SELL	$36.43 - $49.4 $141,676 - $192,116	-3,889 Reduced 8.58%	41,411 $1.64 Million
Q2 2022 Aug 15, 2022	SELL	$40.85 - $77.67 $11,192 - $21,281	-274 Reduced 0.6%	45,300 $1.99 Million
Q1 2022 May 13, 2022	BUY	$59.95 - $92.06 $22,421 - $34,430	374 Added 0.83%	45,574 $3.3 Million
Q3 2021 Nov 10, 2021	SELL	$101.99 - $166.36 $2.44 Million - $3.98 Million	-23,921 Reduced 34.61%	45,200 $5.26 Million
Q2 2021 Jul 30, 2021	SELL	$141.6 - $179.06 $198,240 - $250,684	-1,400 Reduced 1.99%	69,121 $11.5 Million
Q1 2021 May 06, 2021	SELL	$132.81 - $182.18 $385,149 - $528,322	-2,900 Reduced 3.95%	70,521 $9.84 Million
Q3 2020 Nov 12, 2020	SELL	$114.09 - $145.51 $1.31 Million - $1.67 Million	-11,459 Reduced 13.5%	73,421 $10.2 Million
Q2 2020 Aug 13, 2020	BUY	$89.45 - $129.85 $1.65 Million - $2.39 Million	18,410 Added 27.7%	84,880 $10.1 Million
Q1 2020 May 14, 2020	BUY	$70.23 - $144.31 $1.6 Million - $3.29 Million	22,770 Added 52.11%	66,470 $6.65 Million
Q4 2019 Feb 18, 2020	BUY	$76.41 - $117.54 $145,179 - $223,326	1,900 Added 4.55%	43,700 $5.14 Million
Q2 2019 Aug 14, 2019	SELL	$58.04 - $66.99 $3.8 Million - $4.39 Million	-65,500 Reduced 61.04%	41,800 $2.71 Million
Q1 2019 May 14, 2019	SELL	$35.52 - $62.62 $781,440 - $1.38 Million	-22,000 Reduced 17.01%	107,300 $6.71 Million
Q4 2018 Feb 13, 2019	SELL	$35.43 - $56.29 $2.46 Million - $3.91 Million	-69,527 Reduced 34.97%	129,300 $5.03 Million
Q3 2018 Nov 08, 2018	SELL	$44.22 - $75.47 $49.4 Million - $84.4 Million	-1,117,761 Reduced 84.9%	198,827 $11.3 Million
Q2 2018 Aug 13, 2018	SELL	$72.38 - $92.5 $14.9 Million - $19 Million	-205,460 Reduced 13.5%	1,316,588 $105 Million
Q1 2018 May 14, 2018	BUY	$69.46 - $88.57 $399,256 - $509,100	5,748 Added 0.38%	1,522,048 $132 Million
Q4 2017 Feb 13, 2018	BUY	$65.94 - $93.31 $2.82 Million - $4 Million	42,823 Added 2.91%	1,516,300 $105 Million
Q3 2017 Nov 13, 2017	BUY	$80.87 - $91.08 $119 Million - $134 Million	1,473,477	1,473,477 $134 Million

Others Institutions Holding NVRO

# of Institutions

145

Shares Held

37.6M

Call Options Held

622K

Put Options Held

1.39M

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $203M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Nevro Corp Transaction History